AUSTIN, Texas, Dec. 19, 2025 /PRNewswire/ — Feel30 , a telehealth platform specializing in testosterone replacement therapy and men’s hormone optimization, has AUSTIN, Texas, Dec. 19, 2025 /PRNewswire/ — Feel30 , a telehealth platform specializing in testosterone replacement therapy and men’s hormone optimization, has

Feel30 Launches Austin-Based Telehealth Platform for Evidence-Proven TRT & Integrated At-Home Phlebotomy Services

AUSTIN, Texas, Dec. 19, 2025 /PRNewswire/ — Feel30 , a telehealth platform specializing in testosterone replacement therapy and men’s hormone optimization, has introduced a care model designed to improve access to clinically supervised treatment. Based in Austin, the service provides evidence-based TRT, enclomiphene treatment, and erectile dysfunction medications prescribed by licensed U.S. clinicians, with medications fulfilled through licensed U.S. pharmacies.

Feel30 launches national telehealth TRT with at-home nurse blood draws.

Feel30 was founded on 22nd February 2025, by entrepreneur Thomas Phillips, who sought to address common problems in traditional hormone care, including long wait times, multiple in-person lab visits, slow or delayed pharmacy compounding, confusing pricing with hidden fees, and rigid schedules. 

Internal data from Feel30’s early patient population shows that 40% of men seek evaluation primarily due to sustained low energy compared to earlier stages of life, while 30% enroll after relocating to a new state and needing continuity of TRT care.

Service features include transparent all-inclusive pricing, quarterly at-home nurse blood draws, home or in-clinic lab flexibility, unlimited clinician consultations, discreet pharmacy fulfillment, and scheduling on patients’ terms.

The initial laboratory panel costs $99 to $129 and includes the lab test, the at-home nurse visit or in-clinic option, the medical intake, and the clinician review. Ongoing treatment starts at $199 to $235 per month and includes medication, quarterly at-home nurse blood draws, unlimited clinician consultations, follow-up care, medication management, and discreet shipping. There are no upsells or hidden fees.

The care process begins with a comprehensive blood panel to evaluate testosterone levels and related biomarkers. Patients can receive at-home nurse visits as early as the next day, with optional in-clinic laboratory testing available. Feel30’s licensed clinicians review results and issue prescriptions only when medically appropriate and aligned with established guidelines. Most patients complete their initial evaluation within 48 to 72 hours.

Feel30 is one of the only national TRT providers offering quarterly at-home phlebotomy included in the base membership price, positioning it as a leading option for men seeking convenient, medically supervised hormone therapy.

According to established Endocrine Society guidelines, testosterone therapy should only be prescribed after laboratory testing confirms low testosterone. Testosterone levels naturally decline with age, and clinically low levels may be associated with symptoms like fatigue, reduced libido, decreased muscle mass, increased body fat, and lower motivation. Enclomiphene may be used to increase endogenous testosterone production while preserving fertility.

“Many men experience delays in hormone evaluation because of limited appointment availability or the inconvenience of accessing laboratory services,” said Anneliese Cadena, AGNP-C, board-certified Nurse Practitioner and consultant for Feel30. “Telehealth combined with at-home diagnostics allows timely evaluation and guideline-based prescribing with ongoing medical oversight.”
Telehealth continues to increase in men’s hormone care as patients seek faster evaluation and more flexible access to licensed clinicians. Integrated care models allow clinicians to assess laboratory data remotely, prescribe treatment, and follow up with patients.

Media Contact: Thomas Phillips, support@feel30.com, 833-545-1589

**About Feel30** Feel30 is based in Austin, Texas. The platform provides evidence-based testosterone therapy, enclomiphene treatment, and men’s health services with all-inclusive pricing, at-home lab testing with nurse visits, unlimited clinician support, and fast U.S. pharmacy fulfillment. The company’s mission is to make evidence-based hormone care clearer, faster, and more accessible for busy men nationwide who refuse to wait.

Cision View original content:https://www.prnewswire.com/news-releases/feel30-launches-austin-based-telehealth-platform-for-evidence-proven-trt–integrated-at-home-phlebotomy-services-302646836.html

SOURCE Feel30

Market Opportunity
TRUST AI Logo
TRUST AI Price(TRT)
$0.2684
$0.2684$0.2684
+9.41%
USD
TRUST AI (TRT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Yarm Explained: Turning Trust and Tweets into Yield

Yarm Explained: Turning Trust and Tweets into Yield

tl;dr: Yarm is a new platform by Mitosis and Kaito AI that turns social influence into onchain yield. Yappers earn Mindshare by posting…Continue reading on Coinmonks »
Share
Medium2025/09/18 14:43
Crossmint Partners with MoneyGram for USDC Remittances in Colombia

Crossmint Partners with MoneyGram for USDC Remittances in Colombia

TLDR Crossmint enables MoneyGram’s new stablecoin payment app for cross-border transfers. The new app allows USDC transfers from the US to Colombia, boosting financial inclusion. MoneyGram offers USDC savings and Visa-linked spending for Colombian users. The collaboration simplifies cross-border payments with enterprise-grade blockchain tech. MoneyGram, a global leader in remittance services, launched its stablecoin-powered cross-border [...] The post Crossmint Partners with MoneyGram for USDC Remittances in Colombia appeared first on CoinCentral.
Share
Coincentral2025/09/18 21:02
US SEC suspends trading in shares of digital asset treasury firms QMMM and Smart Digital

US SEC suspends trading in shares of digital asset treasury firms QMMM and Smart Digital

PANews reported on September 30th that the U.S. Securities and Exchange Commission (SEC) has suspended trading in QMMM Holdings Ltd.'s stock after its share price surged nearly 1,000% in less than three weeks, according to Bloomberg. The SEC stated on Monday that recommendations to buy QMMM stock posted on social media by "unidentified individuals" may have manipulated its share price. Since QMMM announced earlier this month that it would establish a "diversified cryptocurrency treasury" with an initial investment of $100 million, targeting investments in Bitcoin, Ethereum, and Solana, its share price has surged 959%. The SEC stated that the trading suspension is a temporary measure and will end at 11:59 PM EST on October 10th. On Monday, the SEC also suspended trading in Smart Digital Group Ltd.'s shares for similar reasons. The suspension will also expire at 11:59 PM ET on October 10. The company announced last week that it would establish a "diversified cryptocurrency asset pool," focusing on digital assets like Bitcoin and Ethereum. Since the announcement, its stock price has fallen significantly.
Share
PANews2025/09/30 08:32